Arkolith/Insider Trading/CTIC/Form 4

Craig Adam R

President and CEO, DirectorCTI BIOPHARMA CORP (CTIC) · full profile →Form 4 · filed Jan 26, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$512K
Net Open-Market Flow
-$512K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2023Option exercise(M)83K$0.84$70K113K
Jan 24, 2023Sell(S)2K$6.01$13K29K
Jan 24, 2023Option exercise(M)2K$0.84$2K32K
Jan 24, 2023Sell(S)83K$6.00$499K29K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 24, 2023Option exercise(M)83K—$0472K
Jan 24, 2023Option exercise(M)2K—$0470K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000891293-23-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML